Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

NCT01303965 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Multiple Myeloma

Interventions

DRUG: Sirolimus
DRUG: Tacrolimus
DRUG: Lenalidomide

Sponsor

Sherif S. Farag

Collaborators

[object Object]